We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,978 results
  1. Protective effect of SERCA2a-SUMOylation by SUMO-1 on diabetes-induced atherosclerosis and aortic vascular injury

    Abstract

    Diabetes is a major risk factor for cardiovascular disease. However, the exact mechanism by which diabetes contributes to vascular damage is...

    **lin Liu, Shifang Xu, ... Rui Guo in Molecular and Cellular Biochemistry
    Article 05 March 2024
  2. 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis

    Autophagy inducers can prevent cardiovascular aging and age-associated diseases including atherosclerosis. Therefore, we hypothesized that...

    Giulia Cerrato, Carlota Alvarez-Lucena, ... Guido Kroemer in Cell Death & Disease
    Article Open access 22 November 2023
  3. DNA Methylation Profiling in Aneurysm and Comorbid Atherosclerosis of the Ascending Aorta

    Abstract

    Atherosclerosis and aneurysm of the aorta are relatively common pathological conditions that remain asymptomatic for a long period of time...

    I. A. Goncharova, A. A. Zarubin, ... M. S. Nazarenko in Molecular Biology
    Article 05 June 2024
  4. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis

    Disordered lipid accumulation in the arterial wall is a hallmark of atherosclerosis. Previous studies found that the expression of triggering...

    **aoqing Guo, Bowei Li, ... Ling Mao in Cellular and Molecular Life Sciences
    Article 03 May 2023
  5. Atherosclerosis antigens as targets for immunotherapy

    Atherosclerosis is a chronic inflammatory disease of the arteries that can lead to thrombosis, infarction and stroke, underlying the first cause of...

    Irene Raposo-Gutiérrez, Ana Rodríguez-Ronchel, Almudena R. Ramiro in Nature Cardiovascular Research
    Article 11 December 2023
  6. Macrophage polarization and metabolism in atherosclerosis

    Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of fatty deposits in the inner walls of vessels. These plaques...

    Pengbo Hou, Jiankai Fang, ... Gerry Melino in Cell Death & Disease
    Article Open access 20 October 2023
  7. The role of CNPY2 in endothelial injury and inflammation during the progress of atherosclerosis

    Vascular endothelial cells (VECs) injury is closely related to the occurrence and development of atherosclerosis. Canopy FGF signaling regulator 2...

    Hong Huang, Ning Tang, ... Qiang Meng in Journal of Molecular Histology
    Article 27 April 2023
  8. TREM2 protects from atherosclerosis by limiting necrotic core formation

    Atherosclerosis is a chronic disease of the vascular wall driven by lipid accumulation and inflammation in the intimal layer of arteries, and its...

    Marie Piollet, Florentina Porsch, ... Clément Cochain in Nature Cardiovascular Research
    Article Open access 12 March 2024
  9. PKCδ regulates the vascular biology in diabetic atherosclerosis

    Diabetes mellitus, known for its complications, especially vascular complications, is becoming a globally serious social problem. Atherosclerosis has...

    Peiliang Qin, Changhuai He, ... Yiqing Li in Cell Communication and Signaling
    Article Open access 16 November 2023
  10. Adropin inhibits the progression of atherosclerosis in ApoE-/-/Enho-/- mice by regulating endothelial-to-mesenchymal transition

    Adropin, a secreted protein, coded by energy homeostasis-associated gene (Enho), is recently reported to modulate atherogenesis, with...

    Teng Ying, LingZhen Wu, ... Jun Fang in Cell Death Discovery
    Article Open access 31 October 2023
  11. Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis

    Endothelial injury and dysfunction in the artery wall fuel the process of atherosclerosis. As a key epigenetic regulator, Ash2l (Absent, small, or...

    Zhenghua Su, **ghuan Wang, ... Yi Zhun Zhu in Cellular and Molecular Life Sciences
    Article Open access 27 January 2024
  12. Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway

    Background

    Atherosclerosis (AS) is a persistent inflammatory condition triggered and exacerbated by several factors including lipid accumulation,...

    Heng Wang, Qinqin Tian, ... Honglin Dong in Lipids in Health and Disease
    Article Open access 11 March 2024
  13. Noncoding RNAs in atherosclerosis: regulation and therapeutic potential

    Atherosclerosis, a chronic disease of arteries, results in high mortality worldwide as the leading cause of cardiovascular disease. The development...

    Luyao Qi, Jixiang **ng, ... Ming Lei in Molecular and Cellular Biochemistry
    Article Open access 07 July 2023
  14. Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis

    Atherosclerosis is driven by the expansion of cholesterol-loaded ‘foamy’ macrophages in the arterial intima. Factors regulating foamy macrophage...

    Michael T. Patterson, Maria M. Firulyova, ... Jesse W. Williams in Nature Cardiovascular Research
    Article Open access 30 October 2023
  15. Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis

    Background

    Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a...

    Daopeng Dai, Zhengbin Zhu, ... **zhou Zhu in BMC Biology
    Article Open access 10 July 2023
  16. Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation

    Atherosclerosis, in general, is an age-associated cardiovascular disease wherein a progressive decline in mitochondrial function due to aging majorly...

    Sriravali Pulipaka, Gajalakshmi Singuru, ... Srigiridhar Kotamraju in GeroScience
    Article 16 November 2023
  17. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities

    Accumulating evidence over the past decades has revealed an intricate relationship between dysregulation of cellular metabolism and the progression...

    Chad Stroope, Felix Sebastian Nettersheim, ... Arif Yurdagul Jr. in Nature Metabolism
    Article 26 March 2024
  18. DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy

    Atherosclerosis, which is a vascular pathology characterized by inflammation and plaque build-up within arterial vessel walls, acts as the important...

    Liang Zhang, Chenhai **a, ... Ming Yuan in Cell Communication and Signaling
    Article Open access 29 November 2023
  19. Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis

    CCL17 is produced by conventional dendritic cells, signals through CCR4 on regulatory T (T reg ) cells and drives atherosclerosis by suppressing T reg ...

    Yvonne Döring, Emiel P. C. van der Vorst, ... Christian Weber in Nature Cardiovascular Research
    Article Open access 22 January 2024
  20. DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice

    Atherosclerosis evolves through dysregulated lipid metabolism interwoven with exaggerated inflammation. Previous work implicating the receptor for...

    Laura Senatus, Lander Egaña-Gorroño, ... Ann Marie Schmidt in Communications Biology
    Article Open access 17 March 2023
Did you find what you were looking for? Share feedback.